protalix biotherapeutics inc
Transactions by PROTALIX BIOTHERAPEUTICS INC (PLX) in the last 6 months
Yelin Lapidot Investment House and others entered into an agreement to acquire 4.7% stake in Protalix BioTherapeutics, Inc. (AMEX:PLX) from Bio-Cell Ltd. for $10.9 million on August 12, 2014. Bio-Cell sold 4.4 million shares of Protalix BioTherapeutics at $2.47 each. As a result of transaction, Bio-Cell’s shareholding in Protalix BioTherapeutics reduced to approximately 10.47% stake. Yelin Lapidot acquired 2% stake in Protalix BioTherapeutics for ILS 15 million. Bio-Cell ...
|No competitor information is available for PLX.|
|View Industry Companies|
|Price/Cash Flow||--||Not Meaningful|